Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure insights into selective coupling of G protein subtypes by a class B G protein-coupled receptor. | Nat Commun | 2022 | 36335102 | PubTator, text mining | PubMed |
| Identification of nine novel variants across PAX3, SOX10, EDNRB, and MITF genes in Waardenburg syndrome with next-generation sequencing. | Mol Genet Genomic Med | 2022 | 36331148 | PubTator, text mining | PubMed |
| Elements of the ERAD ubiquitin ligase Doa10 regulating sequential poly-ubiquitylation of its targets. | iScience | 2022 | 36325070 | PubTator, text mining | PubMed |
| Phosphatidic Acid Mediates the Nem1-Spo7/Pah1 Phosphatase Cascade in Yeast Lipid Synthesis. | J Lipid Res | 2022 | 36314526 | PubTator, text mining | PubMed |
| One class classification for the detection of β2 adrenergic receptor agonists using single-ligand dynamic interaction data. | J Cheminform | 2022 | 36309734 | PubTator, text mining | PubMed |
| Kinase Fusion-Related Thyroid Carcinomas: Towards Predictive Models for Advanced Actionable Diagnostics. | Endocr Pathol | 2022 | 36308634 | PubTator, text mining | PubMed |
| Inhibition mechanism of NKCC1 involves the carboxyl terminus and long-range conformational coupling. | Sci Adv | 2022 | 36306358 | PubTator, text mining | PubMed |
| Identification of Cofilin-1 as a novel biomarker of atopic dermatitis using iTRAQ quantitative proteomics. | J Clin Lab Anal | 2022 | 36305098 | PubTator, text mining | PubMed |
| Clinicopathological Features of Inflammatory Myofibroblastic Tumor in the Breast. | Breast J | 2022 | 36304484 | PubTator, text mining | PubMed |
| Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease. | Drugs Context | 2022 | 36303600 | PubTator, text mining | PubMed |
| Towards Precision Oncology: The Role of Smoothened and Its Variants in Cancer. | J Pers Med | 2022 | 36294790 | PubTator, text mining | PubMed |
| Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas. | Cancers (Basel) | 2022 | 36291756 | PubTator, text mining | PubMed |
| Reshaping the Binding Pocket of the Neurotransmitter:Solute Symporter (NSS) Family Transporter SLC6A14 (ATB0,+) Selectively Reduces Access for Cationic Amino Acids and Derivatives. | Biomolecules | 2022 | 36291613 | PubTator, text mining | PubMed |
| Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma. | Cells | 2022 | 36291095 | PubTator, text mining | PubMed |
| Adenocarcinomas of the Lung and Neurotrophin System: A Review. | Biomedicines | 2022 | 36289793 | PubTator, text mining | PubMed |
| Biased signaling due to oligomerization of the G protein-coupled platelet-activating factor receptor. | Nat Commun | 2022 | 36289206 | PubTator, text mining | PubMed |
| Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot. | Int J Neonatal Screen | 2022 | 36278620 | PubTator, text mining | PubMed |
| Cryo-EM structures of thermostabilized prestin provide mechanistic insights underlying outer hair cell electromotility. | Nat Commun | 2022 | 36266333 | PubTator, text mining | PubMed |
| Survival benefit of combinatorial osimertinib rechallenge and entrectinib in an EGFR-mutant NSCLC patient with acquired LMNA-NTRK1 fusion following osimertinib resistance. | Respirol Case Rep | 2022 | 36258694 | PubTator, text mining | PubMed |
| Structural and functional investigation of ABC transporter STE6-2p from Pichia pastoris reveals unexpected interaction with sterol molecules. | Proc Natl Acad Sci U S A | 2022 | 36256814 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=29